Skip to Content

NVR 7P5 (Afinitor 7.5 mg)

Generic Name: everolimus

Pill with imprint NVR 7P5 is White, Elliptical / Oval and has been identified as Afinitor 7.5 mg. It is supplied by Novartis Pharmaceuticals.

Afinitor is used in the treatment of neuroendocrine carcinoma; breast cancer; pancreatic cancer; renal angiomyolipoma; renal cell carcinoma and belongs to the drug classes mTOR inhibitors, selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Afinitor 7.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for NVR 7P5

Afinitor 7.5 mg NVR 7P5

Afinitor

Generic Name
everolimus
Imprint
NVR 7P5
Strength
7.5 mg
Color
White
Size
15.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
MTOR inhibitors, Selective immunosuppressants
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Novartis Pharmaceuticals
National Drug Code (NDC)
00078-0620
Inactive Ingredients
butylated hydroxytoluene, crospovidone, hypromelloses, lactose anhydrous, lactose monohydrate, magnesium stearate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.